News

4D Molecular Therapeutics to Spotlight at Cystic Fibrosis Event

4D Molecular Therapeutics to Spotlight at Cystic Fibrosis Event

4D Molecular Therapeutics Set to Shine at the 2024 Cystic Fibrosis Conference

EMERYVILLE, Calif. – 4D Molecular Therapeutics (NASDAQ: FDMT), a trailblazer in genetic medicine, is preparing for a key presentation at the upcoming 2024 North American Cystic Fibrosis Conference (NACFC). This exciting event will take place in Boston from September 26-28, where 4DMT will highlight its recent advancements.

Overview of the 2024 NACFC Presentation

4DMT is thrilled to present a compelling poster titled "Transgene expression and CFTR channel function in human bronchial epithelial cells following addition of CFTR modulators and 4D-710." This presentation will explore innovative solutions that have the potential to improve treatment methods for cystic fibrosis.

Details on the Poster Session

You can find their poster featured in Poster Session 344. Attendees are encouraged to stop by and discover more about the groundbreaking work being done by 4D Molecular Therapeutics.

When to Attend the Presentation

Don’t forget to mark your calendar for Friday, September 27, 2024, from 1:15 to 2:15 p.m. ET. Dr. Melissa A. Calton, the VP of Early-Stage Product Development, and her team will be present to discuss their findings and address any questions you may have.

About 4D Molecular Therapeutics

4DMT focuses on developing clinical-stage genetic medicines aimed at tackling complex diseases in vital areas like ophthalmology and pulmonology. Their innovative Therapeutic Vector Evolution platform uses cutting-edge directed evolution technology, incorporating around one billion synthetic AAV capsid-derived sequences to create tailored vectors that enhance treatment effectiveness.

Innovative Product Pipeline

With a strong pipeline that features six clinical-stage products and one in preclinical development, 4DMT is working on therapies designed for both rare and common diseases across multiple medical fields, such as cardiology and central nervous system disorders.

Dedication to Progress

The company is deeply committed to transforming medicine through potentially curative therapies. Their continuous advancements offer hope for millions struggling with genetic disorders.

Future Vision and Directions

4DMT aims not only to create effective therapies but also to ensure that these treatments reach the patients who need them the most. Their ongoing research and development initiatives focus on delivering innovative and effective solutions to the market, offering long-lasting treatments for various genetically related diseases.

Contact Information

If you have any questions or need more information, please reach out to:

Media Contact:
Katherine Smith
Inizio Evoke Comms
Media@4DMT.com

Investor Relations:
Julian Pei
Head of Investor Relations and Corporate Finance
Investor.Relations@4DMT.com

Frequently Asked Questions

What is the focus of 4D Molecular Therapeutics?

4DMT is dedicated to creating genetic medicines targeting various diseases, especially in the fields of ophthalmology and pulmonology.

When and where is 4DMT presenting?

4DMT will be presenting at the 2024 North American Cystic Fibrosis Conference from September 26-28 in Boston.

What is the title of 4DMT's presentation?

The title of the presentation is "Transgene expression and CFTR channel function in human bronchial epithelial cells following addition of CFTR modulators and 4D-710."

Who will be presenting at the conference?

The presentation will be led by Dr. Melissa A. Calton, who serves as the VP of Early-Stage Product Development at 4DMT.

How can I learn more about 4DMT?

You can visit 4D Molecular Therapeutics’ website to find more information about their ongoing projects, recent news, and advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Standards Touch 2027 Student Paper Competition

Updated Category News Views 59

Diving into Trust: ANSI's 2027 Paper Challenge Out from the buzz of New York, the American National Standards Institute (ANSI) has stirred up some real brain-teasing talk for students across the country. Kicking off the 2027 Student Paper Competition, they're handing students a chance to ponder a question we take for granted every day. Do we ever truly consider what makes...

Continue Reading
Glance's Guide Bridges AI and Human Service Gaps

Updated Category News Views 117

Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 196

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
Aemetis Faces Class Action Over Wage Violation Claims

Updated Category News Views 83

California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...

Continue Reading
Federal Realty Boosts Outlook with Q3 Gains

Updated Category News Views 88

Numbers That Matter: Solid Q3 Performance Federal Realty Investment Trust's (NYSE: FRT) latest numbers paint a rosy picture—fading the gloom and doom for the moment. The steady climb from $0.69 to $0.74 in diluted EPS from last year is one thing, but it’s the 5.6% boost in Nareit-defined and Core funds from operations per diluted share that's catching eyes, now...

Continue Reading
Flash Tech Sparks New Era in Gas Sensing

Updated Category News Views 38

Revolutionary 10-Millisecond Flash Technique Out of South Korea comes a scientific shake-up that's got eyes on a tiny flash of light poised to change gas sensing technology as we know it. Yep, at Hanyang University ERICA, the boffins have figured out how a quick-fire 10-millisecond zap can turn up the sensitivity dial on gas sensors, especially for the pesky nitrogen...

Continue Reading
CACI Hits $50K Milestone in Service Dog Program

Updated Category News Views 96

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

Continue Reading
Jewelry Repair and Resizing Demystified by Expert

Updated Category News Views 135

The Magic of Fixing Sparkles When it comes to keeping those sparkly trinkets as charming as ever, nothing beats a well-timed fix-up. Jewelry repair isn’t just about patching up old necklaces or battered rings; it’s an art of bringing worn-out pieces back to life. I’m talking about the sort of work that Mike Littlejohn at Carbaugh Jewelers breaks down in a recent...

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 80

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading
Hot Chili Sizzles with La Verde Copper Drill Gains

Updated Category News Views 95

Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...

Continue Reading

Top 5 Most Recently Viewed Articles

STRADVISION Unveils Advanced SVNet 3D Perception Network at CES

Updated Category News Views 132

STRADVISION to Showcase the SVNet 3D Perception Network at CES STRADVISION, a prominent player in AI-driven vision perception technology, is gearing up to reveal its innovative SVNet 3D Perception Network at CES 2025. This event, widely recognized as a global technology showcase, will take place in Las Vegas, providing an excellent platform for the company to present its...

Continue Reading
Capricor Therapeutics: Important Information for Investors

Updated Category News Views 137

Understanding the Capricor Therapeutics Lawsuit Investors buying into Capricor Therapeutics, Inc. (NASDAQ: CAPR) during a defined period should be aware of significant developments. The law firm of Rosen has announced that purchasers of Capricor securities between specific dates may be eligible to take lead roles in a class action lawsuit. This lawsuit is a reflection of...

Continue Reading
Experience Groceryshop 2024 with Ja Rule as Headliner

Updated Category News Views 177

Groceryshop 2024: An Event to Remember Groceryshop 2024 is shaping up to be a pivotal event in the grocery and consumer packaged goods (CPG) sector, and what better way to celebrate than with the electrifying performance of Grammy-nominated artist Ja Rule? Known for his chart-topping hits and dynamic stage presence, Ja Rule will headline Groceryfest, the signature...

Continue Reading
Exploring the Rising Trends and Innovations in Low Rolling Resistance Tires

Updated Category News Views 121

An Overview of the Low Rolling Resistance Tire Market The global low rolling resistance tire market is on an exciting growth path, projected to reach a remarkable USD 20.5 billion by 2024. Growth is expected to pick up speed, with a forecasted Compound Annual Growth Rate (CAGR) of 11.7%, potentially hitting USD 55.6 billion by 2034. As the automotive industry shifts...

Continue Reading
Intra-Cellular Therapies Unveils Promising Data on Lumateperone

Updated Category News Views 79

New Insights on Lumateperone Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) has made exciting progress in the field of depression treatment. They recently shared important data from Study 501 regarding lumateperone, showcasing its potential as a supplementary therapy for major depressive disorder (MDD). Highlights from the ECNP Congress During the 37th European College of...

Continue Reading